Heart Failure Prevention Is the Best Option To Stem High Costs and Disease Burden Research for More Effective Heart Failure Treatment Is Needed

被引：2

作者：

Desvigne-Nickens, Patrice ^{[1
]}

机构：

[1] NHLBI, Heart Failure & Arrhythmia Branch, Div Cardiovas Sci, Bethesda, MD 20892 USA

来源：

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2011年 / 4卷 / 02期

关键词：

Editorials; healthcare disparities; heart failure; hypertension; prevention; ISOSORBIDE DINITRATE; MORTALITY; HYPERTENSION; HYDRALAZINE; BLACKS; RACE;

D O I：

10.1161/CIRCOUTCOMES.111.960641

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：143 / 145

页数：3

共 21 条

[1] Racial Differences in Incident Heart Failure among Young Adults [J].

Bibbins-Domingo, Kirsten ;

Pletcher, Mark J. ;

Lin, Feng ;

Vittinghoff, Eric ;

Gardin, Julius M. ;

Arynchyn, Alexander ;

Lewis, Cora E. ;

Williams, O. Dale ;

Hulley, Stephen B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (12) :1179-1190

[2] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].

Chobanian, AV ;

Bakris, GL ;

Black, HR ;

Cushman, WC ;

Green, LA ;

Izzo, JL ;

Jones, DW ;

Materson, BJ ;

Oparil, S ;

Wright, JT ;

Roccella, EJ .

HYPERTENSION, 2003, 42 (06) :1206-1252

[3] EFFECT OF VASODILATOR THERAPY ON MORTALITY IN CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY [J].

COHN, JN ;

ARCHIBALD, DG ;

ZIESCHE, S ;

FRANCIOSA, JA ;

HARSTON, WE ;

TRISTANI, FE ;

DUNKMAN, WB ;

JACOBS, W ;

FRANCIS, GS ;

FLOHR, KH ;

GOLDMAN, S ;

COBB, FR ;

SHAH, PM ;

SAUNDERS, R ;

FLETCHER, RD ;

LOEB, HS ;

HUGHES, VC ;

BAKER, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24) :1547-1552

[4] A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE [J].

COHN, JN ;

JOHNSON, G ;

ZIESCHE, S ;

COBB, F ;

FRANCIS, G ;

TRISTANI, F ;

SMITH, R ;

DUNKMAN, WB ;

LOEB, H ;

WONG, ML ;

BHAT, G ;

GOLDMAN, S ;

FLETCHER, RD ;

DOHERTY, J ;

HUGHES, CV ;

CARSON, P ;

CINTRON, G ;

SHABETAI, R ;

HAAKENSON, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) :303-310

[5] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[6]

DAVIGLUS M, 2006, AM J CARDIOVASC DRUG, V6, P98

[7] Primary prevention of heart failure: an update [J].

Dupree, Carla S. .

CURRENT OPINION IN CARDIOLOGY, 2010, 25 (05) :478-483

[8] National Heart, Lung, and Blood Institute-Initiated Program "Interventions to Improve Hypertension Control Rates in African Americans" Background and Implementation [J].

Einhorn, Paula T. .

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (03) :236-240

[9] Mortality After Hospitalization for Heart Failure in Blacks Compared to Whites [J].

Gordon, Howard S. ;

Nowlin, Patrick R. ;

Maynard, Daniel ;

Berbaum, Michael L. ;

Deswal, Anita .

AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (05) :694-700

[10]

HOOVER LE, 2007, JAMA-J AM MED ASSOC, V99, P690

← 1 2 3 →